Search Bar & Filters
Found 2 Actively Recruiting clinical trials
Actively Recruiting
Researchers are evaluating the impact of a brief motivational intervention BMI delivered by pharmacists on reducing the use of benzodiazepines and related drugs BZDZ in adults who have been using these medications long term. The study aims to compare this intervention against usual pharmacy dispensing practices, focusing on reducing daily drug doses and monitoring clinical symptoms related to anxiety and sleep disorders. The research addresses concerns about the widespread long-term use of BZDZ and the need for practical deprescribing strategies in primary care. Participants will be randomly assigned to either receive the BMI, which involves identifying patients and using motivational techniques to encourage dose reduction, or to continue with standard pharmacy care without this intervention. The intervention targets adults with at least six months of continuous BZDZ use. The study will evaluate effects at 6 and 12 months, with repeated assessments of drug dose, cessation rates, clinical symptoms, misuse, and adverse events. During the study, participants will complete questionnaires and undergo clinical evaluations to measure anxiety, depression, insomnia severity, and any clinical worsening. Data on drug misuse and transfers to other addictive behaviors will also be collected. Safety will be monitored through adverse event reporting at multiple time points up to 12 months. Overall, the study spans at least 12 months to assess both short- and longer-term outcomes of the intervention.
Actively Recruiting
Nearly half of all patients who stay in intensive care experience symptoms of anxiety and depression, with one in five developing post-traumatic stress disorder. Improving patient experience in the ICU is a priority, especially by recreating familiar environments. Animal-assisted interventions, particularly with dogs, have been used successfully in elderly and psychiatric patients to reduce anxiety and stress, though visits with a patients own pet are less common and may face challenges such as behavioral or infection risks. This study evaluates the feasibility of allowing intensive care patients to be visited by their own pets for 20 minutes. The intervention involves patients receiving visits from their own dogs or cats while in the ICU. The study focuses on assessing how practical and safe these visits are within the intensive care setting. Participants will be adults who are conscious and no longer in acute respiratory or hemodynamic failure, and who own a pet. Researchers will assess the feasibility of pet visits by Day 15 and collect data on patient mood, care received, microbiological impact on patients and the ICU environment, and patient satisfaction over three months. The study includes monitoring for any infection risks and evaluates patient experiences throughout their participation.